Like Canopy Growth (TSX:WEED)? This Pot Stock Is Even Better

Canopy Growth (TSX:WEED)(NYSE:CGC) is a favourite among cannabis investors. With a $10.3 billion market cap, the stock is priced above nearly every competitor. One of the biggest reasons for this valuation is Canopy’s partnership with Constellation Brands. With a $40 billion valuation, Constellation is an industry heavyweight, too. But instead of pot, Constellation is focused on alcohol. Last year, it…

Read More

Don’t Buy Canopy Growth (TSX:WEED) Stock: These Pot Stocks Take the Cake

Canopy Growth Corp (TSX:WEED)(NYSE:CGC) is one of the most loved cannabis stocks on the market. With a valuation of $8.6 billion, it’s also one of the largest. One of the biggest reasons for Canopy’s vaunted position is Constellation Brands, Inc. (NYSE:STZ). Constellation is a highly successful consumer brand company. With the rights to globally recognized brands like Modelo and Corona,…

Read More

Is Canopy Growth (TSX:WEED) Stock a Buy After New CEO Appointment?

Marijuana leader Canopy Growth (TSX:WEED)(NYSE:CGC) stock rallied over 11% on Monday after the company finally announced new CEO David Klein as the preferred replacement for ousted co-founder Bruce Linton and the stepping down of interim leader and co-founder Mark Zekulin later this month. The new CEO will assume the reins on January 14 of 2020. Canopy has clearly decided to…

Read More

Bank of America (NYSE:BAC) Says This Cannabis Stock Is Now a Buy

Bank of America analysts haven’t always been bullish on cannabis stocks, but due to the recent industry-wide decline, they’re jumping in. On November 20, the firm upgraded shares of Canopy Growth (TSX:WEED)(NYSE:CGC) to “buy,” noting that consensus estimates are finally “achievable (even beatable).” A big part of the upgrade was valuation. Since April, Canopy shares have lost two-thirds of their…

Read More

Forget Canopy Growth (TSX:WEED): Why This Pot Stock Could Triple in Value!

Canopy Growth (TSX:WEED)(NYSE:CGC) has been on a rough ride this year, falling more than 45% in six months and falling to below $30 a share. While it’s likely attracted the attention of investors thinking that it could be a good buy, whether that’s the case is questionable. Let’s not forget that this is the company that is still looking for…

Read More

2 Cannabis Stocks That Could Land a Game-Changing Partner in 2020

Last year, nearly every cannabis company was racing to find a big-time partner. Cronos Group, for example, secured a $1.8 billion deal with tobacco giant Altria Group. Cronos stock ran more than 100% on the news, rising to a peak market cap of $20 billion. Canopy Growth, meanwhile, locked down a $4 billion capital infusion from Constellation Brands, causing shares…

Read More

2019 Canadian Election: Cannabis Fatigue

Cannabis was the hot topic in the 2015 election. Legal weed garnered Canada global attention and ignited an even more rigorous debate over how the industry would be structured and regulated after the Liberal victory. The push for legal weed was hugely consequential for investors and sparked a gold rush in the fledgling sector. Canada finally crossed the finish line…

Read More

Why Hexo (TSX:HEXO) Is the Best Cannabis Stock to Buy Right Now

Here’s my case as to why shares in Hexo (TSX:HEXO)(NYSE:HEXO), right now trading not far off their respective 52-week lows, could very well be the best investment anywhere among cannabis stocks today. HEXO is a large cannabis company, granted, it’s not quite at the same levels as the likes of Canopy Growth, Aurora Cannabis, or Cronos Group, each of which…

Read More

Is Canopy Growth Corp. (TSX:WEED) Stock a Buy Below $30?

The downward trend in marijuana stocks continues to send share prices to new 12-month lows. This is a very different situation compared to the massive rally the sector enjoyed in the first two weeks of last October ahead of the launch of the legal recreational market in Canada. Canopy Growth (TSX:WEED)(NYSE:CGC) traded above $73 per share on October 15, 2018.…

Read More